Agree ablm, a detailed update is just as important as any deal announcement. No point in doing deals if the back end of what needs to be done to generate recurring revenue can’t be completed..
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025